Methylation of the MGMT promoter or inactivating mutations have been associated with several cancer types, including colorectal cancer, lung cancer, prostate cancer, lymphoma, glioblastoma, and astrocytoma [62–64]. Here, MGMT is linked to astrocytoma (excluding glioblastoma).